Latest news with #ScienceGroup
Yahoo
15-05-2025
- Business
- Yahoo
Exploring European Undervalued Small Caps With Insider Action
As European markets continue to navigate a complex landscape of trade tensions and economic shifts, the pan-European STOXX Europe 600 Index has shown resilience, rising for a fourth consecutive week amid hopes for easing trade disputes. In this environment, small-cap stocks have garnered attention due to their potential for growth and agility in adapting to changing conditions. Identifying promising opportunities among these smaller companies often involves looking at factors such as strong fundamentals, strategic positioning within their industries, and any insider actions that might signal confidence in future performance. Name PE PS Discount to Fair Value Value Rating Morgan Advanced Materials 12.2x 0.6x 34.09% ★★★★★☆ Savills 24.9x 0.6x 40.44% ★★★★☆☆ FRP Advisory Group 12.1x 2.2x 17.18% ★★★★☆☆ AKVA group 15.1x 0.7x 49.19% ★★★★☆☆ Close Brothers Group NA 0.6x 48.10% ★★★★☆☆ Eastnine 18.1x 8.7x 39.64% ★★★★☆☆ Absolent Air Care Group 24.1x 1.9x 45.67% ★★★☆☆☆ Italmobiliare 11.6x 1.5x -204.97% ★★★☆☆☆ Arendals Fossekompani NA 1.7x 39.12% ★★★☆☆☆ Seeing Machines NA 2.5x 43.87% ★★★☆☆☆ Click here to see the full list of 65 stocks from our Undervalued European Small Caps With Insider Buying screener. Let's review some notable picks from our screened stocks. Simply Wall St Value Rating: ★★★★★☆ Overview: Science Group operates in consultancy services, audio chips and modules, and submarine atmosphere management systems, with a market capitalization of £0.21 billion. Operations: Consultancy Services is the primary revenue stream, contributing £72.21 million, followed by Systems - Submarine Atmosphere Management at £25.86 million and Systems - Audio Chips and Modules at £11.97 million. The gross profit margin showed a notable increase from 23.77% to 48.21% over the observed periods before settling around 40%. PE: 16.7x Science Group, a smaller European company, has shown mixed financial performance. For 2024, sales slightly decreased to £110.67 million from £113.34 million the previous year, but net income more than doubled to £12.02 million. Earnings per share increased significantly as well. They completed a buyback of over 1 million shares for £4.69 million in late 2024, indicating insider confidence in their value proposition despite potential earnings decline and reliance on external borrowing for funding. Unlock comprehensive insights into our analysis of Science Group stock in this valuation report. Evaluate Science Group's historical performance by accessing our past performance report. Simply Wall St Value Rating: ★★★★★★ Overview: Sanlorenzo is a luxury yacht manufacturer with operations in the Yacht, Bluegame, Superyacht, and Nautor Swan divisions, and it has a market capitalization of €1.51 billion. Operations: The company generates revenue primarily from the Yacht, Bluegame, Superyacht, and Nautor Swan divisions. The gross profit margin saw an increase to 29.24% by the end of 2024, reflecting a notable rise in profitability. PE: 10.5x Sanlorenzo, a prominent player in the luxury yacht industry, showcases potential as an undervalued investment. The company reported a net income of €103.12 million for 2024, up from €92.84 million the previous year, with earnings per share at €2.92. Insider confidence is evident as Massimo Perotti acquired 30,000 shares valued at approximately €842K in March 2025, reflecting trust in future growth despite reliance on external borrowing for funding. Earnings are projected to grow by 4.45% annually, suggesting steady progress ahead. Dive into the specifics of Sanlorenzo here with our thorough valuation report. Gain insights into Sanlorenzo's historical performance by reviewing our past performance report. Simply Wall St Value Rating: ★★★★★☆ Overview: Vanquis Banking Group operates in the financial services sector, providing credit cards, loans, vehicle finance, and second charge mortgages, with a market capitalization of approximately £0.42 billion. Operations: Vanquis Banking Group's revenue streams are primarily driven by its Cards segment, contributing £238.10 million, and Vehicle Finance at £34.20 million. The company experienced fluctuations in its net income margin, peaking at 32.75% in Q4 2016 before encountering significant declines to -44.28% by the end of 2024. PE: -1.6x Vanquis Banking Group, a small-cap player in the European financial sector, faces challenges with a reported net loss of £119.3 million for 2024, compared to a £11.7 million loss in 2023. The absence of customer deposits means reliance on external borrowing, adding risk to its funding structure. Despite these hurdles, insider confidence remains as insiders have been purchasing shares over the past six months. Earnings are projected to grow significantly at 85% annually, suggesting potential recovery and growth opportunities ahead. Take a closer look at Vanquis Banking Group's potential here in our valuation report. Learn about Vanquis Banking Group's historical performance. Embark on your investment journey to our 65 Undervalued European Small Caps With Insider Buying selection here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:SAG BIT:SL and LSE:VANQ. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
01-05-2025
- Business
- Reuters
Science Group calls meeting of Ricardo shareholders to oust chairman
May 1 (Reuters) - Science Group (SAGS.L), opens new tab on Thursday said that it has requisitioned a general meeting of shareholders at Ricardo (RCDO.L), opens new tab to propose the removal of its Chairman Mark Clare, ramping up calls for change at the British consulting firm.
Yahoo
29-04-2025
- Business
- Yahoo
Undiscovered Gems with Strong Fundamentals in April 2025
In the current landscape, the UK market has been grappling with challenges as evidenced by the recent declines in key indices like the FTSE 100 and FTSE 250, driven by weak trade data from China and broader global economic concerns. Despite these headwinds, investors can find opportunities in stocks with strong fundamentals that are well-positioned to weather such uncertainties. Name Debt To Equity Revenue Growth Earnings Growth Health Rating BioPharma Credit NA 7.22% 7.91% ★★★★★★ B.P. Marsh & Partners NA 29.42% 31.34% ★★★★★★ Livermore Investments Group NA 9.92% 13.65% ★★★★★★ Andrews Sykes Group NA 2.15% 4.93% ★★★★★★ Rights and Issues Investment Trust NA -7.87% -8.41% ★★★★★★ London Security 0.22% 10.13% 7.75% ★★★★★★ MS INTERNATIONAL NA 13.42% 56.55% ★★★★★★ Goodwin 37.02% 9.75% 15.68% ★★★★★☆ FW Thorpe 2.95% 11.79% 13.49% ★★★★★☆ AltynGold 73.21% 26.90% 31.85% ★★★★☆☆ Click here to see the full list of 59 stocks from our UK Undiscovered Gems With Strong Fundamentals screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Value Rating: ★★★★★★ Overview: Science Group plc is a science, engineering, and technology company that offers consultancy services and systems solutions across the UK, Europe, North America, Asia, and globally with a market capitalization of £196.19 million. Operations: Science Group generates revenue primarily from consultancy services (£72.21 million) and systems businesses, including audio chips and modules (£11.97 million) and submarine atmosphere management (£25.86 million). The company also earns from freehold properties (£3.95 million), while inter-company property income is recorded as negative (-£3.31 million). Science Group, a nimble player in the UK market, has demonstrated robust financial health with its debt to equity ratio dropping from 45% to 14% over five years. The company boasts high-quality earnings and impressive interest coverage of 104.8 times EBIT, ensuring stability. Despite a slight dip in sales to £110.67 million from £113.34 million, net income surged to £12.02 million from £5.52 million last year, reflecting strong profit growth of 117.6%. Trading at a significant discount of 50.7% below estimated fair value and completing a share buyback worth £4.69 million enhances its appeal as an investment prospect. Dive into the specifics of Science Group here with our thorough health report. Examine Science Group's past performance report to understand how it has performed in the past. Simply Wall St Value Rating: ★★★★★★ Overview: BioPharma Credit PLC is an investment trust that focuses on investing in interest-bearing debt assets, with a market cap of $966.70 million. Operations: The company generates revenue primarily through its investments in debt assets secured by royalties, amounting to $150.03 million. BioPharma Credit shines with a robust financial profile, boasting earnings growth of 12.7% over the past year, outpacing the Capital Markets industry average of 7.4%. The company operates debt-free, eliminating concerns around interest coverage and enhancing its financial flexibility. Trading at a notable 31.1% below estimated fair value suggests potential for appreciation. Recent results show revenue climbing to US$150 million from US$135 million in the previous year, while net income reached US$122 million compared to US$108 million prior. A buyback saw the repurchase of over 79 million shares for $69.65 million, reflecting confidence in its valuation and future prospects. Navigate through the intricacies of BioPharma Credit with our comprehensive health report here. Review our historical performance report to gain insights into BioPharma Credit's's past performance. Simply Wall St Value Rating: ★★★★☆☆ Overview: McBride plc, with a market cap of £246.81 million, manufactures and sells private label household and personal care products to retailers and brand owners across the United Kingdom, Europe, Asia-Pacific, and other international markets. Operations: McBride generates revenue primarily from its Liquids segment (£535.30 million) and Unit Dosing segment (£235.20 million), with additional contributions from Powders, Aerosols, and Asia Pacific segments. Trading at a significant discount, McBride stands out with its earnings growth of 122.2% last year, outpacing the household products industry average of 26.1%. The company's net income rose to £19.4 million from £12.7 million, while basic earnings per share increased to £0.114 from £0.073 in the same period last year. Despite a high net debt to equity ratio of 135.8%, its interest payments are well covered by EBIT at 7.8 times coverage, reflecting solid financial management amidst a high debt backdrop and offering potential value for investors seeking opportunities in smaller firms within the UK market. Click here to discover the nuances of McBride with our detailed analytical health report. Gain insights into McBride's historical performance by reviewing our past performance report. Click this link to deep-dive into the 59 companies within our UK Undiscovered Gems With Strong Fundamentals screener. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:SAG LSE:BPCR and LSE:MCB. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
28-04-2025
- Business
- Yahoo
Uncovering UK Penny Stocks: Science Group And Two More To Watch
The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping amid weak trade data from China, highlighting global economic uncertainties. In such a climate, investors may find value in penny stocks—an investment area that remains relevant despite its somewhat outdated name. These smaller or newer companies can offer growth potential and financial strength, making them intriguing options for those seeking under-the-radar opportunities. Name Share Price Market Cap Financial Health Rating Croma Security Solutions Group (AIM:CSSG) £0.855 £11.77M ★★★★★★ Ultimate Products (LSE:ULTP) £0.634 £53.53M ★★★★★☆ LSL Property Services (LSE:LSL) £2.76 £284.91M ★★★★★☆ Warpaint London (AIM:W7L) £3.85 £311.03M ★★★★★★ Foresight Group Holdings (LSE:FSG) £3.69 £416.99M ★★★★★★ Polar Capital Holdings (AIM:POLR) £3.745 £361.01M ★★★★★★ Cairn Homes (LSE:CRN) £1.598 £992.98M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £0.976 £155.66M ★★★★★★ QinetiQ Group (LSE:QQ.) £3.87 £2.13B ★★★★★☆ Van Elle Holdings (AIM:VANL) £0.345 £37.33M ★★★★★★ Click here to see the full list of 386 stocks from our UK Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Science Group plc is a science, engineering, and technology company offering consultancy services and systems businesses globally, with a market cap of £193.96 million. Operations: The company's revenue is primarily derived from consultancy services (£72.21 million) and systems, including audio chips and modules (£11.97 million) as well as submarine atmosphere management (£25.86 million), with additional income from freehold properties (£3.95 million). Market Cap: £193.96M Science Group plc, with a market cap of £193.96 million, demonstrates promising financial stability and growth potential among penny stocks. The company reported a significant increase in net income to £12.02 million for 2024 compared to the previous year and improved profit margins from 4.9% to 10.9%. Its recent buyback of shares worth £4.69 million indicates strong cash flow management, further supported by its high-quality earnings and well-covered debt levels by operating cash flow (156.9%). Despite trading below estimated fair value and analyst price targets suggesting potential upside, future earnings are forecasted to slightly decline by an average of 0.9% annually over the next three years. Unlock comprehensive insights into our analysis of Science Group stock in this financial health report. Understand Science Group's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Alphawave IP Group plc is a company that develops and sells wired connectivity solutions across various global regions, with a market cap of £886.33 million. Operations: The company's revenue from the Communications Equipment segment is $307.59 million. Market Cap: £886.33M Alphawave IP Group plc, with a market cap of £886.33 million, presents an intriguing case among penny stocks due to its strong revenue generation in the Communications Equipment segment at US$307.59 million for 2024, despite reporting a net loss of US$42.52 million. Recent M&A interest from major players like Arm Holdings and Qualcomm highlights its strategic importance in the semiconductor space, though no acquisition has materialized yet. The company's robust optoelectronics portfolio targets a high-growth market projected to exceed US$4 billion by 2028, while maintaining sufficient cash runway for over three years amidst volatility and unprofitability challenges. Click to explore a detailed breakdown of our findings in Alphawave IP Group's financial health report. Assess Alphawave IP Group's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Taylor Maritime Limited is an investment company focused on acquiring, managing, and operating dry bulk ships, with a market cap of $263.17 million. Operations: The company generates revenue of $92.25 million from its shipping vessels, which are utilized to produce investment returns while preserving capital. Market Cap: $263.17M Taylor Maritime Limited, with a market cap of US$263.17 million, stands out in the penny stock arena by achieving profitability recently, driven by its dry bulk shipping operations generating US$92.25 million in revenue. The company maintains a debt-free balance sheet and covers short-term liabilities with assets of US$4.3 million against liabilities of US$2.6 million. Despite stable weekly volatility at 4%, Taylor Maritime trades at 24.9% below estimated fair value, suggesting potential undervaluation. Recent executive appointments aim to bolster strategic direction and governance as it navigates the complexities of maritime investments while distributing dividends to shareholders. Navigate through the intricacies of Taylor Maritime with our comprehensive balance sheet health report here. Gain insights into Taylor Maritime's past trends and performance with our report on the company's historical track record. Access the full spectrum of 386 UK Penny Stocks by clicking on this link. Contemplating Other Strategies? This technology could replace computers: discover the 21 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:SAG LSE:AWE and LSE:TMI. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
25-03-2025
- Business
- Yahoo
Science Group And 2 Other UK Penny Stocks With Promising Prospects
The UK stock market has faced challenges recently, with the FTSE 100 index experiencing declines amid weak trade data from China, highlighting broader global economic concerns. In such a fluctuating market landscape, identifying stocks with solid fundamentals becomes crucial. Penny stocks, often smaller or newer companies, may offer unique growth opportunities when backed by strong financials and balance sheet resilience. Name Share Price Market Cap Financial Health Rating Ultimate Products (LSE:ULTP) £0.714 £60.53M ★★★★★★ Next 15 Group (AIM:NFG) £3.005 £298.87M ★★★★☆☆ Helios Underwriting (AIM:HUW) £2.08 £148.39M ★★★★★☆ Warpaint London (AIM:W7L) £4.20 £339.31M ★★★★★★ Foresight Group Holdings (LSE:FSG) £3.63 £412.89M ★★★★★★ City of London Investment Group (LSE:CLIG) £3.30 £162.63M ★★★★★★ Polar Capital Holdings (AIM:POLR) £4.43 £427.04M ★★★★★★ Begbies Traynor Group (AIM:BEG) £1.015 £161.76M ★★★★★★ QinetiQ Group (LSE:QQ.) £3.784 £2.1B ★★★★★☆ Van Elle Holdings (AIM:VANL) £0.32 £34.62M ★★★★★★ Click here to see the full list of 448 stocks from our UK Penny Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Science Group plc is a science, engineering, and technology company offering consultancy services and systems businesses across the UK, Europe, North America, Asia, and internationally with a market cap of £189.79 million. Operations: The company has not reported any specific revenue segments. Market Cap: £189.79M Science Group plc, with a market cap of £189.79 million, has demonstrated robust financial health and growth potential. The company reported a net income increase to £12.02 million for 2024, up from £5.52 million the previous year, while maintaining stable weekly volatility at 2%. Its interest payments are well-covered by EBIT at 15.3 times coverage and its debt is fully covered by operating cash flow (156.9%). With short-term assets exceeding liabilities and no significant shareholder dilution recently, Science Group remains financially sound despite earnings forecasted to decline slightly over the next three years by an average of 1.6% annually. Click to explore a detailed breakdown of our findings in Science Group's financial health report. Examine Science Group's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Virgin Wines UK PLC is a direct-to-consumer online wine retailer in the United Kingdom with a market cap of £27.63 million. Operations: The company's revenue is primarily derived from the sale of alcohol, amounting to £59.01 million. Market Cap: £27.63M Virgin Wines UK PLC, with a market cap of £27.63 million, has recently become profitable, though its earnings have declined by 23.8% annually over the past five years. The company operates without debt, alleviating concerns about interest payments and cash flow coverage. Short-term assets of £26.9 million comfortably exceed both short-term and long-term liabilities, reflecting financial stability despite low return on equity at 5.9%. Recent management changes include Amanda Cherry succeeding Graeme Weir as CFO in April 2025 after his significant contributions to the company's growth trajectory since its IPO in 2021 and private equity-backed buyout in 2013. Jump into the full analysis health report here for a deeper understanding of Virgin Wines UK. Explore Virgin Wines UK's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: S4 Capital plc, with a market cap of £211.94 million, offers digital advertising and marketing services across the Americas, Europe, the Middle East, Africa, and the Asia Pacific through its subsidiaries. Operations: S4 Capital does not report specific revenue segments. Market Cap: £211.94M S4 Capital plc, with a market cap of £211.94 million, is currently unprofitable but maintains a positive cash flow and sufficient cash runway for over three years. Despite trading at 60.8% below its estimated fair value, the company faces challenges with increased net loss to £306.9 million in 2024 from £14.3 million the previous year. However, it benefits from strong asset coverage over liabilities and a satisfactory net debt to equity ratio of 24.1%. Recent leadership appointments aim to leverage AI-powered services for growth amid industry shifts toward digital transformation and marketing integration strategies. Click here and access our complete financial health analysis report to understand the dynamics of S4 Capital. Review our growth performance report to gain insights into S4 Capital's future. Unlock more gems! Our UK Penny Stocks screener has unearthed 445 more companies for you to here to unveil our expertly curated list of 448 UK Penny Stocks. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:SAG AIM:VINO and LSE:SFOR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
